How big is the ambulatory infusion centers market?

Strategic Revenue Insights estimates the global ambulatory infusion centers market at USD 12.40 billion in 2025, rising to USD 28.82 billion by 2035 at an 8.80 percent compound annual growth rate.

Why is infusion moving out of hospitals?

Payers are steering patients to lower-cost settings, biologics and immunotherapies are increasing the number of patients needing regular infusions, and operators are building purpose-designed centers in retail and medical office space.

Which ambulatory infusion segments lead?

Oncology chemotherapy is the largest therapy segment and immunotherapy and biologics the fastest growing. Hospital-affiliated centers are the largest ownership model, cancer is the largest indication and North America the largest region.

What drives the ambulatory infusion centers market?

Chronic disease prevalence, the shift to value-based and outpatient care, government support, advances in infusion devices and digital health, and growth in home infusion drive the market.